Clinical Trials in Calgary, Alberta

Find clinical trials in Calgary, Alberta. Discover local research opportunities and treatment options in your area.

565 Active Trials Found in Calgary

Showing 565 trials on this page

Page 1 of 29

Two Dose Levels of Privigen in Pediatric CIDP

NCT ID: NCT03684018

This clinical trial, titled “Two Dose Levels of Privigen in Pediatric CIDP,” is studying the effects of a medication called Privigen on children and teenagers aged 2 to 17 who have been diagnosed w...

Recruiting

Phase: PHASE4 Conditions: Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

NCT ID: NCT04176198

This clinical trial is investigating a new oral medication called nuvisertib (TP-3654) for patients with myelofibrosis, a type of blood cancer that affects the bone marrow and can lead to severe sy...

Recruiting

Phase: PHASE1 Conditions: Myelofibrosis

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant

NCT ID: NCT05317416

This clinical trial is studying a new treatment called elranatamab to see if it is more effective than a standard treatment called lenalidomide for patients with newly diagnosed multiple myeloma wh...

Recruiting

Phase: PHASE3 Conditions: Multiple Myeloma

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

NCT ID: NCT05636176

This clinical trial is studying a new treatment called ziltivekimab for people with heart failure who also have inflammation. Heart failure means the heart isn't pumping blood as well as it should,...

Recruiting

Phase: PHASE3 Conditions: Heart Failure

A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.

NCT ID: NCT05984277

The eVOLVE-Lung02 clinical trial is studying a new treatment for patients with metastatic non-small cell lung cancer (NSCLC), which is a type of lung cancer that has spread to other parts of the bo...

Recruiting

Phase: PHASE3 Conditions: Metastatic Non-small Cell Lung Cancer

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

NCT ID: NCT06118281

The ARTEMIS clinical trial is investigating a new medication called ziltivekimab, which researchers hope can help people who have recently had a heart attack. The goal is to see if ziltivekimab can...

Recruiting

Phase: PHASE3 Conditions: Cardiovascular Risk, Acute Myocardial Infarction (AMI)

A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation

NCT ID: NCT06200207

This clinical trial is studying a new medicine called ziltivekimab to see how well it works for people with heart failure and inflammation. Participants in the study will either receive ziltivekima...

Recruiting

Phase: PHASE3 Conditions: Heart Failure, Systemic Inflammation

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NCT ID: NCT06548360

This clinical trial is studying a new cream called ruxolitinib to see if it is safe and effective for children with nonsegmental vitiligo, a condition where patches of skin lose their color. The tr...

Recruiting

Phase: PHASE3 Conditions: NonSegmental Vitiligo

A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

NCT ID: NCT06551324

This clinical trial, called MEVPRO-1, is looking at a new medicine called PF-06821497 (Mevrometostat) to see if it can help men with metastatic castrate-resistant prostate cancer (mCRPC) who have p...

Recruiting

Phase: PHASE3 Conditions: Metastatic Castrate Resistant Prostate Cancer (mCRPC)

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

NCT ID: NCT06585774

This clinical trial is studying a new treatment option for patients with moderate or severe chronic graft-versus-host disease (cGVHD), a condition that can occur after a stem cell or bone marrow tr...

Recruiting

Phase: PHASE3 Conditions: Chronic Graft-versus-host-disease

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

NCT ID: NCT06615479

This clinical trial, called QUINTESSENTIAL-2, is testing a new treatment called BMS-986393 to see how well it works compared to standard treatments for adults with relapsed or refractory multiple m...

Recruiting

Phase: PHASE3 Conditions: Relapsed or Refractory Multiple Myeloma (RRMM)

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

NCT ID: NCT06629779

This clinical trial is studying a new drug called PF-06821497 (also known as Mevrometostat) to see if it works better when combined with another medication called enzalutamide for men with metastat...

Recruiting

Phase: PHASE3 Conditions: Metastatic Castration-Resistant Prostate Cancer

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

NCT ID: NCT06832618

This clinical trial is looking at a new cream called ruxolitinib to see if it is effective and safe for children and teenagers aged 6 to under 18 who have moderate atopic dermatitis, which is a typ...

Recruiting

Phase: PHASE3 Conditions: Atopic Dermatitis

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

NCT ID: NCT06855498

This clinical trial is a continuation study for people who have already participated in earlier studies involving a medication called povorcitinib, which is being tested for a skin condition known ...

Recruiting

Phase: PHASE3 Conditions: Hidradenitis Suppurativa (HS)

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

NCT ID: NCT06959225

This clinical trial, called TRuE-HS1, is looking at the effectiveness and safety of a cream called ruxolitinib for treating people with hidradenitis suppurativa (HS), a painful skin condition. The ...

Recruiting

Phase: PHASE3 Conditions: Hidradenitis Suppurativa

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

NCT ID: NCT02418442

The CARRA Registry is an ongoing study that focuses on children and young adults with rheumatic joint diseases, which are conditions that cause pain and inflammation in the joints. This study aims ...

Recruiting

Conditions: Rheumatic Joint Disease

A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis

NCT ID: NCT03165734

This clinical trial is studying a medication called pacritinib to see how well it works for patients with specific types of myelofibrosis, which is a serious blood disorder that affects bone marrow...

Recruiting

Phase: PHASE3 Conditions: Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis +1 more

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

NCT ID: NCT06637631

This clinical trial is looking at a new treatment called SAR441566 for adults with moderate to severe Crohn's Disease, a condition that causes inflammation in the digestive tract. The goal is to se...

Recruiting

Phase: PHASE2 Conditions: Crohn's Disease

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

NCT ID: NCT06989112

The DESTINY-Endometrial01 trial is a research study looking at new treatment options for women with a specific type of advanced or recurrent endometrial cancer, which is a cancer of the uterus. Thi...

Recruiting

Phase: PHASE3 Conditions: Endometrial Cancer

Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia

NCT ID: NCT04994717

This clinical trial is studying a new treatment approach for older adults with a type of blood cancer called Philadelphia-negative B-cell precursor acute lymphoblastic leukemia (ALL). The trial com...

Recruiting

Phase: PHASE3 Conditions: Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)